Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-06-29 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text, which is very short (398 characters), announces that Novozymes initiated a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (No. 2273/2003) for up to 1,000 million DKK between January 20, 2012, and December 31, 2012. This directly relates to the company buying back its own shares. The classification 'Transaction in Own Shares' (POS) is the most appropriate fit. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a brief announcement, but the core content is a definitive transaction notice, making POS stronger than RPA/RNS, as it describes the action itself rather than just announcing the publication of a report.
2012-06-29 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' and details the amount and period for buying back 'B shares'. This directly relates to the company repurchasing its own stock. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text ends with 'Read the full announcement in PDF format,' suggesting it might be an RPA, the core content is a direct announcement of the buyback program itself, making POS the most accurate classification for the subject matter, especially given the short length which implies this is the primary announcement.
2012-06-29 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'share buyback program' initiated by Novozymes, providing specific dates, number of shares bought, and transaction values. This directly relates to the company managing its own stock. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The content is a detailed report of these transactions, not just an announcement of a report's publication.
2012-06-22 English
Director's Dealing 2012
Director's Dealing
2012-06-22 Danish
Regulatory Filings 2012
Regulatory Filings Classification · 99% confidence The document text explicitly discusses Novozymes initiating a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (Commission Regulation No 2273/2003). This activity directly relates to the company transacting in its own shares. The classification code for this activity is 'POS' (Transaction in Own Shares). Although the text ends with 'Læs hele meddelel´sen i pdf format' (Read the entire announcement in pdf format), which suggests an RPA, the core content is a definitive announcement of a share repurchase program, making POS the primary classification, as it is a specific announcement type, not just a generic report publication notice.
2012-06-15 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document text details specific transactions made by Novozymes under an authorized share buyback program ('aktietilbagekøbsprogram') between January 20, 2012, and December 31, 2012, referencing the 'Safe Harbour' regulation. It provides daily transaction volumes, average purchase prices, and updates the total number of treasury shares held. This activity directly relates to the company managing its own stock capital. The classification 'Transaction in Own Shares' (POS) is the most precise fit for reporting the execution of a share repurchase program, as opposed to a general capital change (SHA) or a mere announcement of a report (RPA). The document length is short (2667 chars), but it contains the actual data/report of the transactions, not just an announcement that the data exists elsewhere.
2012-06-15 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.